The company's statement on inflation indicates a potential lack of pricing power, which could compress margins. This suggests a need for solutions that can optimize pricing, justify value, or reduce cost of goods sold to protect profitability.
Filing excerpt
Sustained inflationary pressures in the future may have an adverse effect on our ability to maintain current levels of gross margin and operating expenses as a percentage of net revenue if we are unable to offset such higher costs through price increases.
What this signalsFilings often name leadership changes, deals and spending plans.
sec-10qpricingPressureGet every 10-Q signal for ResMed and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at ResMed this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/e6cc96f1-40a9-4815-ae3c-e6a4d26629dd returns this record as JSON. POST /v1/companies/enrich returns every signal for resmed.com.
{
"signal_id": "e6cc96f1-40a9-4815-ae3c-e6a4d26629dd",
"signal_type": "sec-10q",
"signal_subtype": "pricingPressure",
"detected_at": "2026-05-05T08:48:22.301+00:00",
"company": {
"name": "ResMed",
"domain": "resmed.com"
},
"data": {
"detail": "The company's statement on inflation indicates a potential lack of pricing power, which could compress margins. This suggests a need for solutions that can optimize pricing, justify value, or reduce cost of goods sold to protect profitability.",
"metrics": {
"timeframe": "current_quarter"
},
"summary": "ResMed flags potential inability to pass on rising costs through price increases.",
"excerpts": "Sustained inflationary pressures in the future may have an adverse effect on our ability to maintain current levels of gross margin and operating expenses as a percentage of net revenue if we are unable to offset such higher costs through price increases.",
"relevance": 0.7,
"sentiment": "negative",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/943819/000094381926000025/rmd-20260331.htm",
"filing_date": "2026-04-30",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "03/31",
"sales_relevance": "Cost optimization needed",
"signal_category": "market"
}
}
curl https://signals.autobound.ai/v1/signals/e6cc96f1-40a9-4815-ae3c-e6a4d26629dd \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"resmed.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.